ReviewGHM open2024
Materiality of evidence-based policy making for child and adolescent psychiatry in Japan.
Review in GHM open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Rising cognitive behavioral therapy claims among Japanese youth despite population decline: A retrospective study using the National Database of Health Insurance Claims (FY 20142022).Global health & medicine · 2025Article
- Association Between Dreams, Anxiety, and Depressive Symptoms Among Japanese Adolescents: A Cross-Sectional Study.Clocks & sleep · 2025Article
- Comparative study on school-based mental health literacy in three Asian countries.Tropical medicine and health · 2025Article
- Regional disparities in Japanese children's mental health profession shortage areas.PCN reports : psychiatry and clinical neurosciences · 2025Review
- Does the Japanese insurance system increase outpatient psychiatric treatment for children and adolescents? A retrospective study using open data from the national claims database for 2016 to 2022.PCN reports : psychiatry and clinical neurosciences · 2025Article
- The COVID-19 pandemic-induced behavioral restrictions and their impact on child and adolescent psychiatric units-Infection control or freedom.PCN reports : psychiatry and clinical neurosciences · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Japanese government established the Children and Family Agency in April 2023 and is trying to promote evidence-based policymaking (EBPM). However, the current state of child and adolescent psychiatry in Japan demonstrated some difficulties. School refusal and suicide problems are increasing after the coronavirus disease-2019 (COVID-19) pandemic. These issues need to be addressed, thereby warranting various policies to be developed and implemented. Increasing the number of inpatient medical institutions and establishing a community-based data accumulation system that enables data and knowledge sharing among professionals is essential to improve child and adolescent psychiatric care. Furthermore, EBPM is needed to effectively develop a policy, and specialized experts are necessary to organize data and critically review evidence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.